Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name GRP78
   Synonyms NA
   Region GRCh38_9:125234853-125241330    Sequence
   Ensembl ENSG00000044574
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name prostate cancer
   ICD-0-3 C61.9  
   Methods qPCR etc.
   Sample cell line (PC3PCA+ )
   Expression Pattern up-regulated
   Function Description

Three proteins were found down-regulated and 7 proteins up-regulated in PC3PCA+ cells compared to PC3NC cells,including GRP78.Higher GRP78 was also found in PCa clinical specimens.This study confirmed that in PCa, PCA3 plays a pro-cancer role through promoting cell proliferation, migration and invasion while inhibiting cell apoptosis. This process might involve the up-regulation of GRP78.GRP78 was also reported to be preferentially expressed in the camptothecin (CPT)- resistant PC3 prostate cancer cell line in comparison to the CPT-sensitive LNCaP prostate cancer cell line, which indicated its involvement in chemotherapy resistant in PCa.

   Pubmed ID 28739722
   Year 2017
   Title GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
   External Links
   Links for  GRP78 GenBank       HGNC       lncrnadb       Noncode
   Links for  prostate cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.